| Product Name | Thrombospondin-derived Peptide; Cyclic CSVTCG |
| Purity | HPLC>95% |
| Description | This peptide is derived from thrombospondin and represents a binding motif responsible for thrombospondin-CD36 interaction. It is cyclized through a disulfide bond. Thrombospondin is a matrix-bound glycoprotein involved in cancer metastasis, tumor adhesion, and angiogenesis. This peptide has been shown to competitively inhibit platelet aggregation and tumor metastasis. |
| Storage | -20°C |
| References | Wakiyama, T. et al. Histol Histopathol 16, 345 (2001); Tsuzynski, G. et al. J Cell Biol 120, 513 (1993); Asch, A. et al. Biochem Biophys Res Commun 182, 1208 (1992). |
| Molecular Weight | 566.7 |
| Sequence (One-Letter Code) | CSVTCG (S-S Bonded) |
| Sequence (Three-Letter Code) | H - Cys - Ser - Val - Thr - Cys - Gly - OH (S - S Bonded) |
Thrombospondin-derived Peptide; Cyclic CSVTCGAdmin2021-01-06T06:30:03+00:00
